Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12803489rdf:typepubmed:Citationlld:pubmed
pubmed-article:12803489lifeskim:mentionsumls-concept:C0221920lld:lifeskim
pubmed-article:12803489lifeskim:mentionsumls-concept:C0031671lld:lifeskim
pubmed-article:12803489lifeskim:mentionsumls-concept:C0018270lld:lifeskim
pubmed-article:12803489lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:12803489pubmed:issue2lld:pubmed
pubmed-article:12803489pubmed:dateCreated2003-6-13lld:pubmed
pubmed-article:12803489pubmed:abstractTextPhospholipase C-gamma1 (PLC-gamma1) plays pivotal roles in cellular growth and proliferation through its two Src homology (SH) 2 domains and its single SH3 domain, which interact with signaling molecules in response to various growth factors and hormones. However, the role of the SH domains in the growth factor-induced regulation of PLC-gamma1 is unclear. By peptide-mass fingerprinting analysis we have identified Cbl as a binding protein for the SH3 domain of PLC-gamma1 from rat pheochromatocyte PC12 cells. Association of Cbl with PLC-gamma1 was induced by epidermal growth factor (EGF) but not by nerve growth factor (NGF). Upon EGF stimulation, both Cbl and PLC-gamma1 were recruited to the activated EGF receptor through their SH2 domains. Mutation of the SH2 domains of either Cbl or PLC-gamma1 abrogated the EGF-induced interaction of PLC-gamma1 with Cbl, indicating that SH2-mediated translocation is essential for the association of PLC-gamma1 and Cbl. Overexpression of Cbl attenuated EGF-induced tyrosine phosphorylation and the subsequent activation of PLC-gamma1 by interfering competitively with the interaction between PLC-gamma1 and EGFR. Taken together, these results provide the first indications that Cbl may be a negative regulator of intracellular signaling following EGF-induced PLC-gamma1 activation.lld:pubmed
pubmed-article:12803489pubmed:languageenglld:pubmed
pubmed-article:12803489pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12803489pubmed:citationSubsetIMlld:pubmed
pubmed-article:12803489pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12803489pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12803489pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12803489pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12803489pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12803489pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12803489pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12803489pubmed:statusMEDLINElld:pubmed
pubmed-article:12803489pubmed:monthAprlld:pubmed
pubmed-article:12803489pubmed:issn1016-8478lld:pubmed
pubmed-article:12803489pubmed:authorpubmed-author:RyuSung HoSHlld:pubmed
pubmed-article:12803489pubmed:authorpubmed-author:SuhPann-Ghill...lld:pubmed
pubmed-article:12803489pubmed:authorpubmed-author:CoccoLucioLlld:pubmed
pubmed-article:12803489pubmed:authorpubmed-author:BaeSun SikSSlld:pubmed
pubmed-article:12803489pubmed:authorpubmed-author:ParkJong...lld:pubmed
pubmed-article:12803489pubmed:authorpubmed-author:ChoiJang...lld:pubmed
pubmed-article:12803489pubmed:authorpubmed-author:SongHebokHlld:pubmed
pubmed-article:12803489pubmed:authorpubmed-author:KimJae-HoJHlld:pubmed
pubmed-article:12803489pubmed:authorpubmed-author:HaSang HoonSHlld:pubmed
pubmed-article:12803489pubmed:issnTypePrintlld:pubmed
pubmed-article:12803489pubmed:day30lld:pubmed
pubmed-article:12803489pubmed:volume15lld:pubmed
pubmed-article:12803489pubmed:ownerNLMlld:pubmed
pubmed-article:12803489pubmed:authorsCompleteYlld:pubmed
pubmed-article:12803489pubmed:pagination245-55lld:pubmed
pubmed-article:12803489pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:12803489pubmed:meshHeadingpubmed-meshheading:12803489...lld:pubmed
pubmed-article:12803489pubmed:meshHeadingpubmed-meshheading:12803489...lld:pubmed
pubmed-article:12803489pubmed:meshHeadingpubmed-meshheading:12803489...lld:pubmed
pubmed-article:12803489pubmed:meshHeadingpubmed-meshheading:12803489...lld:pubmed
pubmed-article:12803489pubmed:meshHeadingpubmed-meshheading:12803489...lld:pubmed
pubmed-article:12803489pubmed:meshHeadingpubmed-meshheading:12803489...lld:pubmed
pubmed-article:12803489pubmed:meshHeadingpubmed-meshheading:12803489...lld:pubmed
pubmed-article:12803489pubmed:meshHeadingpubmed-meshheading:12803489...lld:pubmed
pubmed-article:12803489pubmed:meshHeadingpubmed-meshheading:12803489...lld:pubmed
pubmed-article:12803489pubmed:meshHeadingpubmed-meshheading:12803489...lld:pubmed
pubmed-article:12803489pubmed:meshHeadingpubmed-meshheading:12803489...lld:pubmed
pubmed-article:12803489pubmed:meshHeadingpubmed-meshheading:12803489...lld:pubmed
pubmed-article:12803489pubmed:year2003lld:pubmed
pubmed-article:12803489pubmed:articleTitleCbl competitively inhibits epidermal growth factor-induced activation of phospholipase C-gamma1.lld:pubmed
pubmed-article:12803489pubmed:affiliationDivision of Molecular and Life Science, Pohang University of Science and Technology, Pohang 790-784, Korea.lld:pubmed
pubmed-article:12803489pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12803489pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:12803489pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:867entrezgene:pubmedpubmed-article:12803489lld:entrezgene
entrez-gene:1956entrezgene:pubmedpubmed-article:12803489lld:entrezgene
entrez-gene:5335entrezgene:pubmedpubmed-article:12803489lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12803489lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12803489lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12803489lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12803489lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12803489lld:pubmed